Screener
Inogen INGN Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$95.1MMiss by $149.3K
EPS-$0.14Beat by $0.01
Revenue estimate$95.2M
EPS estimate-$0.15
“Our second quarter results demonstrate continued demand for our products and validate the progress of our strategy to expand and diversify Inogen's respiratory care portfolio. We are building momentum through new product launches, gaining traction in key markets, and driving greater operating leverage across the business. As we continue to execute against our strategic priorities, we are diligently prioritizing our investments to balance growth, profitability, and innovation to deliver long-term value for shareholders.”
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$92.3M
EPS estimate-$0.11
Financials
Q2 2026Valuation & ratios
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Inogen report Q2 2026 earnings?
- Inogen (INGN) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Inogen's Q2 2026 revenue and EPS?
- Inogen reported revenue of $95.1M and eps of $-0.14 for Q2 2026.
- Did Inogen beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $95.2M by $149.3K. EPS beat the consensus estimate of $-0.15 by $0.01.
- How did Inogen's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 3.0% from $92.3M a year earlier and eps grew 6.7% from $-0.15.
- Where can I find Inogen's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001294133-26-000032) and the 10-Q periodic report (0001294133-26-000034) directly on SEC EDGAR. The filing index links above go to sec.gov.
